Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)

ClinicalTrials.gov ID: NCT00441727

Public ClinicalTrials.gov record NCT00441727. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 9:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Parallel-group, Multicentre, Phase III Study to Assess the Effect of Esomeprazole 20 or 40 mg od Versus Placebo on the Occurrence of Peptic Ulcers During 26 Weeks in Subjects on Continuous Low Dose Acetylsalicylic Acid (ASA)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the effect of esomeprazole 20 or 40 mg once daily versus placebo on the occurrence of peptic ulcers during 26 weeks in subjects on continuous low-dose acetylsalicylic acid.

Study identification

NCT ID
NCT00441727
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
2,426 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2007 (Type not available)
Primary completion
Aug 2008 (Actual)
Completion
Aug 2008 (Actual)
Last update posted
Jul 16, 2012

2007 – 2008

United States locations

U.S. sites
55
U.S. states
26
U.S. cities
55
Facility City State ZIP Site status
Research Site Birmingham Alabama — —
Research Site Tucson Arizona — —
Research Site Anaheim California — —
Research Site Lancaster California — —
Research Site Los Angeles California — —
Research Site Orange California — —
Research Site San Carlos California — —
Research Site San Diego California — —
Research Site Torrington Connecticut — —
Research Site Boynton Beach Florida — —
Research Site Hollywood Florida — —
Research Site Jacksonville Florida — —
Research Site Jupiter Florida — —
Research Site Miami Florida — —
Research Site New Smyrna Beach Florida — —
Research Site Pembroke Pines Florida — —
Research Site Plantation Florida — —
Research Site South Miami Florida — —
Research Site Tampa Florida — —
Research Site Zephyrhills Florida — —
Research Site Fulton Illinois — —
Research Site Wichita Kansas — —
Research Site Shreveport Louisiana — —
Research Site Baltimore Maryland — —
Research Site Hollywood Maryland — —
Research Site Prince Frederick Maryland — —
Research Site Brockton Massachusetts — —
Research Site Jackson Mississippi — —
Research Site Las Vegas Nevada — —
Research Site Egg Harbor New Jersey — —
Research Site Albuquerque New Mexico — —
Research Site Great Neck New York — —
Research Site Fayetteville North Carolina — —
Research Site Greensboro North Carolina — —
Research Site Jacksonville North Carolina — —
Research Site Winston-Salem North Carolina — —
Research Site Centerville Ohio — —
Research Site Cincinnati Ohio — —
Research Site Dayton Ohio — —
Research Site Guthrie Oklahoma — —
Research Site Oklahoma City Oklahoma — —
Research Site Harrisburg Pennsylvania — —
Research Site Cranston Rhode Island — —
Research Site Johnston Rhode Island — —
Research Site Anderson South Carolina — —
Research Site Simpsonville South Carolina — —
Research Site Knoxville Tennessee — —
Research Site Houston Texas — —
Research Site Ogden Utah — —
Research Site Burke Virginia — —
Research Site Chesapeake Virginia — —
Research Site Christiansburg Virginia — —
Research Site Norfolk Virginia — —
Research Site Richmond Virginia — —
Research Site Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 134 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00441727, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 16, 2012 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00441727 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →